The use of individual risks rather than PopulationAverages in cost-effectiveness modeling

Eitemau Tebyg

• The use of individual risks rather than population averages in cost-effectiveness modeling
  gan: Van Staa, T, et al.
  Cyhoeddwyd: (2006)
• Not all patients are average: The importance of epidemiological data in pharmacoeconomic modeling
  gan: van Staa, T, et al.
  Cyhoeddwyd: (2006)
• Not all patients are average: The importance of recognising patient heterogeneity
  gan: Van Staa, T, et al.
  Cyhoeddwyd: (2006)
• Individual fracture risk and the cost-effectiveness of bisphosphonates in patients using oral glucocorticoids.
  gan: van Staa, T, et al.
  Cyhoeddwyd: (2007)
• The cost-effectiveness of bisphosphonates in postmenopausal women based on individual long-term fracture risks.
  gan: van Staa, T, et al.
  Cyhoeddwyd: (2007)